급성기 전기경련치료를 통한 주요우울장애의 우울증상 심각도 변화와 관련된 임상적 요인
Clinical Factors Related to Change of Depression Severity in Major Depressive Disorder Through Index Electroconvulsive Therapy
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objectives：The aim of this study was to investigate the factors associated with changes in depression severity in index electroconvulsive therapy (ECT) for major depressive disorder. Methods：A retrospective analysis was performed on 80 patients with major depressive disorder who received index ECT. The severity of depression was assessed using the Hamilton depression rating scale-17 (HDRS-17). Multiple linear regression analysis and logistic regression analysis were performed to identify the factors associated with the change of depression severity and the predictors of the 50% or greater reduction rate of HDRS-17. Results：55 (68.8%) patients were HDRS-17 score change ≥50% group, and 25 (31.2%) patients were HDRS-17 score change <50% group. HDRS-17 score change ≥50% group had a shorter episode duration before ECT (11.91±8.63 vs 17.68±11.15 weeks, p=0.027) and more ECT sessions (8.60±2.91 vs 6.80±3.34 sessions, p=0.017). The higher baseline score of anxiety (B=0.937, β=0.374, p<0.001), depression (B=0.846, β=0,324, p=0.001), and somatic symptom (B=0.995, β=0.210, p=0.031) dimensions was associated with the change of HDRS-17 score from baseline. The longer episode duration until the start of ECT was associated with lower likelihood of HDRS-17 score change ≥50% (Wald χ2=7.74, OR=1.08, 95% CI: 1.02-1.14, p=0.005). The greater number of ECT sessions predicted the HDRS-17 score change ≥50% (Wald χ2=7.85, OR=0.75, 95% CI=0.62-0.92, p=0.005) Conclusions：In higher baseline anxiety, depression, and somatic symptoms severity, implementing sufficient sessions of ECT in pharmacological treatment phase of relatively shorter duration of major depressive episode may help reduce HDRS-17 score.
Abstract
Objectives：The aim of this study was to investigate the factors associated with changes in depression severity in index electroconvulsive therapy (ECT) for major depressive disorder. Methods：A retrospective analysis was performed on 80 patients with major depressive disorder who received index ECT. The severity of depression was assessed using the Hamilton depression rating scale-17 (HDRS-17). Multiple linear regression analysis and logistic regression analysis were performed to identify the factors associated with the change of depression severity and the predictors of the 50% or greater reduction rate of HDRS-17. Results：55 (68.8%) patients were HDRS-17 score change ≥50% group, and 25 (31.2%) patients were HDRS-17 score change <50% group. HDRS-17 score change ≥50% group had a shorter episode duration before ECT (11.91±8.63 vs 17.68±11.15 weeks, p=0.027) and more ECT sessions (8.60±2.91 vs 6.80±3.34 sessions, p=0.017). The higher baseline score of anxiety (B=0.937, β=0.374, p<0.001), depression (B=0.846, β=0,324, p=0.001), and somatic symptom (B=0.995, β=0.210, p=0.031) dimensions was associated with the change of HDRS-17 score from baseline. The longer episode duration until the start of ECT was associated with lower likelihood of HDRS-17 score change ≥50% (Wald χ2=7.74, OR=1.08, 95% CI: 1.02-1.14, p=0.005). The greater number of ECT sessions predicted the HDRS-17 score change ≥50% (Wald χ2=7.85, OR=0.75, 95% CI=0.62-0.92, p=0.005) Conclusions：In higher baseline anxiety, depression, and somatic symptoms severity, implementing sufficient sessions of ECT in pharmacological treatment phase of relatively shorter duration of major depressive episode may help reduce HDRS-17 score.
참고문헌 (54)
- Bolwig TG, "Electrotherapy for melancholia : the pioneering contributions of Benjamin Franklin and Giovanni Aldini", J ECT, 25, pp.15~18 (2009)
- Weiner RD, "Key updates in the clinical application of electroconvulsive therapy", Int Rev Psychiatry, 29, pp.54~62 (2017)
- van Rooij SJH, "The efficacy and safety of neuromodulation treatments in late-life depression", Curr Treat Options Psychiatry, 7, pp.337~348 (2020)
- Kellner CH, "ECT in treatment-resistant depression", Am J Psychiatry, 169, pp.1238~1244 (2012)
- Andrade C, "Adverse effects of electroconvulsive therapy", Psychiatr Clin North Am, 39, pp.513~530 (2016)
- Datto CJ, "Side effects of electroconvulsive therapy", Depress Anxiety, 12, pp.130~134 (2000)
- Grover S, "ECT in schizophrenia : a review of the evidence", Acta Neuropsychiatr, 31, pp.115~127 (2019)
- Pagnin D, "Efficacy of ECT in depression : a meta-analytic review", J ECT, 20, pp.13~20 (2004)
- Birkenhäger T, "Electroconvulsive therapy : we are hesitant to use the most effective treatment for severe depression", Acta Psychiatr Scand, 141, pp.301~303 (2020)
- van Diermen L, "Prediction of electroconvulsive therapy response and remission in major depression : meta-analysis", Br J Psychiatry, 212, pp.71~80 (2018)
- Kellner CH, "When to consider electroconvulsive therapy(ECT)", Acta Psychiatr Scand, 141, pp.304~315 (2020)
- Hermida AP, "Electroconvulsive therapy in depression : current practice and future direction", Psychiatr Clin North Am, 41, pp.341~353 (2018)
- Li M, "Effects of electroconvulsive therapy on depression and its potential mechanism", Front Psychol, 11, pp.80~ (2020)
- Yrondi A, "Electroconvulsive therapy, depression, the immune system and inflammation: a systematic review", Brain Stimul, 11, pp.29~51 (2018)
- Gryglewski G, "Meta-analysis of brain structural changes after electroconvulsive therapy in depression", Brain Stimul, 14, pp.927~937 (2021)
- Kellner CH, "The FDA final order on ECT devices, finally", J ECT, 35, pp.69~70 (2019)
- Huang CJ, "The relationship between depression symptoms and anxiety symptoms during acute ECT for patients with major depressive disorder", Int J Neuropsychopharmacol, 22, pp.609~615 (2019)
- Dierckx B, "Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression : a meta-analysis", Bipolar Disord, 14, pp.146~150 (2012)
- Gurel SC, "Bi-temporal electroconvulsive therapy efficacy in bipolar and unipolar depression : A retrospective comparison", Asian J Psychiatr, 55, pp.102503~ (2021)
- Geduldig ET, "Electroconvulsive therapy in the elderly : new findings in geriatric depression", Curr Psychiatry Rep, 18, pp.40~ (2016)
- Birkenhäger TK, "Influence of age on the efficacy of electroconvulsive therapy in major depression : a retrospective study", J Affect Disord, 126, pp.257~261 (2010)
- Haq AU, "Response of depression to electroconvulsive therapy : a meta-analysis of clinical predictors", J Clin Psychiatry, 76, pp.1374~1384 (2015)
- American Psychiatric Association, "Diagnostic and statistical manual of mental disorders: DSM-5" (2013), American Psychiatric Pub
- Milev RV, "Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 4. Neurostimulation Treatments", Can J Psychiatry, 61, pp.561~575 (2016)
- Lisanby SH, "Electroconvulsive therapy for depression", N Engl J Med, 357, pp.1939~1945 (2007)
- American Psychiatric Association, "The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging: a task force report of the American Psychiatric Association", American Psychiatric Association, ~ (2001)
- Trajković G, "Reliability of the Hamilton Rating Scale for Depression : a meta-analysis over a period of 49 years", Psychiatry Res, 189, pp.1~9 (2011)
- 이중서, "한국판 Hamilton 우울증 평가 척도의 신뢰도, 타당도 연구", 신경정신의학, 44(4), pp.456~465 (2005), 대한신경정신의학회
- Shafer AB, "Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung", J Clin Psychol, 62, pp.123~146 (2006)
- Bobo WV, "Validation of the 17-item Hamilton Depression Rating Scale definition of response for adults with major depressive disorder using equipercentile linking to Clinical Global Impression scale ratings : analysis of Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study(PGRN-AMPS)data", Hum Psychopharmacol, 31, pp.185~192 (2016)
- Mickey BJ, "Distinct predictors of short-versus long-term depression outcomes following electroconvulsive therapy", J Psychiatr Res, 145, pp.159~166 (2021)
- Espinoza RT, "Electroconvulsive therapy", N Engl J Med, 386, pp.667~672 (2022)
- Prudic J, "Effectiveness of electroconvulsive therapy in community settings", Biol Psychiatry, 55, pp.301~312 (2004)
- Tor PC, "Comparative outcomes in electroconvulsive therapy (ECT): a naturalistic comparison between outcomes in psychosis, mania, depression, psychotic depression and catatonia", Eur Neuropsychopharmacol, 51, pp.43~54 (2021)
- UK ECT Review Group, "Efficacy and safety of electroconvulsive therapy in depressive disorders : a systematic review and meta-analysis", Lancet, 361, pp.799~808 (2003)
- van Duist M, "ECT non-remitters : prognosis and treatment after 12 unilateral electroconvulsive therapy sessions for major depression", J Affect Disord, 272, pp.501~507 (2020)
- van Diermen L, "The Maudsley Staging Method as predictor of electroconvulsive therapy effectiveness in depression", Acta Psychiatr Scand, 138, pp.605~614 (2018)
- Kho KH, "Predictors for the efficacy of electroconvulsive therapy : chart review of a naturalistic study", J Clin Psychiatry, 66, pp.894~899 (2005)
- Tsuchiyama K, "Predicting efficacy of electroconvulsive therapy in major depressive disorder", Psychiatry Clin Neurosci, 59, pp.546~550 (2005)
- Loo CK, "Predictors of response to ultrabrief right unilateral electroconvulsive therapy", J Affect Disord, 130, pp.192~197 (2011)
- Kindler S, "Factors influencing response to bilateral electroconvulsive therapy in major depression", Convuls Ther, 7, pp.245~254 (1991)
- Dombrovski AY, "Predictors of remission after electroconvulsive therapy in unipolar major depression", J Clin Psychiatry, 66, pp.1043~1049 (2005)
- Pinna M, "Clinical and biological predictors of response to electroconvulsive therapy(ECT) : a review", Neurosci Lett, 669, pp.32~42 (2018)
- Gbyl K, "Cortical thickness following electroconvulsive therapy in patients with depression : a longitudinal MRI study", Acta Psychiatr Scand, 140, pp.205~216 (2019)
- Shah PJ, "Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study", Br J Psychiatry, 172, pp.527~532 (1998)
- Feske U, "Clinical outcome of ECT in patients with major depression and comorbid borderline personality disorder", Am J Psychiatry, 161, pp.2073~2080 (2004)
- Fox CA, "Speed of electroconvulsive therapy for depression : effects of electrode placement", Acta Psychiatr Scand, 143, pp.444~452 (2021)
- Dominiak M, "Efficacy, safety and tolerability of formula-based unilateral vs bilateral electroconvulsive therapy in the treatment of major depression: a randomized open label controlled trial", J Psychiatr Res, 133, pp.52~59 (2021)
- Saeed M, "Right unilateral versus bilateral electroconvulsive therapy in patients with clinical depression", Cureus, 13, pp.e18313~ (2021)
- Gaynes BN, "Defining treatment-resistant depression", Depress Anxiety, 37, pp.134~145 (2020)
- Folkerts HW, "Electroconvulsive therapy vs. paroxetine in treatment-resistant depression--a randomized study", Acta Psychiatr Scand, 96, pp.334~342 (1997)
- Khalid N, "The Effectiveness of electroconvulsive therapy in treatment-resistant depression : a naturalistic study", J ECT, 24, pp.141~145 (2008)
- Loef D, "The ratio and interaction between neurotrophin and immune signaling during electroconvulsive therapy in late-life depression", Brain Behav Immun Health, 18, pp.100389~ (2021)
- Dominiak M, "Electroconvulsive therapy and age: effectiveness, safety and tolerability in the treatment of major depression among patients under and over 65 years of age", Pharmaceuticals(Basel), 14, pp.582~ (2021)